Dr. Anand Tharmaratnam is Senior Vice President and Head of Asia Markets. In this role, Dr. Tharmaratnam has extended responsibility for Quintiles’ clinical development and market access businesses across 13 Asia-Pacific countries that account for half the world’s population – including Japan and China, the world’s second- and third-largest biopharmaceutical markets, respectively. Quintiles has more than 8,000 employees in more than 40 locations across Asia-Pacific.
Dr. Tharmaratnam joined Quintiles in April 1997 as a Clinical Pharmacologist at Guys Drug Research Unit, having spent the previous five years working in anesthesiology and critical care medicine in London.
In 1999, he was appointed Medical Director for Quintiles Europe. Two years later, Dr. Tharmaratnam was tasked with setting up the Quintiles ECG lab in Mumbai, India - the first global ECG lab outside Europe or the US. In 2003, he joined Quintiles Japan and was instrumental in setting up international alliances for the business in Hawaii, Brazil and Peru. In August 2004, Dr. Tharmaratnam moved to Singapore and was appointed Chief Executive Officer of Quintiles Southeast Asia, Taiwan and Korea. He has subsequently taken responsibility for all clinical development in Asia.
Dr. Tharmaratnam earned his medical degree from University College London, UK. He is also a member of the Royal College of Anesthetists, UK, and sits on the NMRC (National Medical Research Council) Singapore.